Quest Diagnostics Incorporated · DGX · Next earnings

Quest Diagnostics Incorporated reports Tuesday, Feb 9, 2027

DGX reports before market open with consensus EPS at $2.68 and revenue at $3.04B. Last quarter: Quest Diagnostics: growth broadens, but PAMA remains a headwind

Reports Before market open96 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.68 Calendar consensus
Consensus revenue $3.04B Calendar consensus
Report date Feb 9, 2027 Tuesday, date estimated
Session Before market open 96 days away

Where DGX left off: FY2026 Q3

Full report

Quest Diagnostics: growth broadens, but PAMA remains a headwind

EPS surprise +4.5% Reported $3.00 vs $2.87
Revenue surprise +1.5% Reported $3.10B vs $3.05B
Stock move +1.8% Event window
Subsequent drift 0.0% Up to 20 sessions

Guidance sentiment remained raised, following the prior quarter's increase; the supplied analysis does not provide the new guidance range.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • PAMA rate cuts and uncertainty around the RESULTS Act
  • Wage inflation and higher fuel costs
  • Cybersecurity incident disclosed in an 8-K filing
  • Execution risk for Apple Health and Onclarity
  • ACA exchange disenrollment

Questions analysts left open

  • PAMA rate-cut headwind and offsets
  • Sustainability of volume growth
  • Apple Health adoption and timing
  • Margin pressure from fuel and wages
  • Cybersecurity incident's operational impact

Ask FN2 about DGX next report

Transcript, numbers and history already loaded
What should I watch for in DGX's next earnings report?How did DGX guide last quarter, and is consensus above or below that?Give me the bull and bear case going into DGX earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the DGX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent DGX quarters

All DGX earnings
+1.8%FY2026 Q3+8.6%FY2026 Q2+4.4%FY2026 Q1+7.4%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.